Tissue Regenix Group plc (TRX.L)
GBp 59.5
(0.0%)
GBp 59.5
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 401.43 Thousand | -1.4 Million | -2.44 Million | -5.47 Million | -7.04 Million | -6.76 Million |
| Net Income | -1.37 Million | -2.18 Million | -3.48 Million | -9.7 Million | -6.97 Million | -8.18 Million |
| Depreciation & Amortization | 785.96 Thousand | 921.43 Thousand | 793.27 Thousand | 762 Thousand | 1.04 Million | 1.17 Million |
| Deferred income taxes | -2.1 Million | -2.59 Million | -2.03 Million | -4.43 Million | -4.24 Million | -2.76 Million |
| Stock-based compensation | 342 Thousand | 249 Thousand | 110 Thousand | -37 Thousand | -191.43 Thousand | -72.32 Thousand |
| Change in working capital | -192.26 Thousand | -500.08 Thousand | -340.28 Thousand | -2.94 Million | -2.34 Million | -490 Thousand |
| Other non-cash items | 2.94 Million | 2.7 Million | 2.51 Million | 10.88 Million | 5.66 Million | 3.57 Million |
| Investing Cash Flow | -694.25 Thousand | -884.89 Thousand | -1.48 Million | -1.37 Million | -651 Thousand | -1.97 Million |
| Investments in PPE | -694.25 Thousand | -884.89 Thousand | -1.48 Million | -1.37 Million | -651 Thousand | -406 Thousand |
| Acquisitions | - | - | - | - | - | -1.56 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -332.59 Thousand | -579.88 Thousand | -365.29 Thousand | -212.06 Thousand | -196 Thousand | - |
| Financing Cash Flow | -760.22 Thousand | 1.1 Million | 144.69 Thousand | 14.01 Million | 2.28 Million | 4000.00 |
| Debt repayment | -191.46 Thousand | -1.38 Million | -437.72 Thousand | -504 Thousand | -2.28 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 59.53 Thousand | 7306.50 | - | 13.75 Million | 1000.00 | 4000.00 |
| Other Financing Activities | -628.29 Thousand | 2.48 Million | 582.41 Thousand | 767 Thousand | 4.57 Million | - |
| Accounts receivables | 863.19 Thousand | -569.9 Thousand | -372.28 Thousand | -11 Thousand | 1.07 Million | -1.18 Million |
| Accounts payables | -1.47 Million | 1.01 Million | 115.61 Thousand | -46 Thousand | -1.56 Million | 156 Thousand |
| Inventory | 421.54 Thousand | -944.16 Thousand | -83.61 Thousand | -2.88 Million | -1.85 Million | 542 Thousand |
| Other working capital | -1.83 Million | -1.00 | - | - | - | - |
| Cash at beginning of period | 4.94 Million | 5.69 Million | 9.55 Million | 2.38 Million | 7.81 Million | 16.42 Million |
| Cash at end of period | 3.64 Million | 4.94 Million | 5.69 Million | 9.55 Million | 2.38 Million | 7.81 Million |
| Capital Expenditure | -694.25 Thousand | -884.89 Thousand | -1.48 Million | -1.37 Million | -651 Thousand | -406 Thousand |
| Effect of forex changes on cash | 10 Thousand | -294 Thousand | -48 Thousand | 81 Thousand | -30.15 Thousand | 158.61 Thousand |
| Net cash flow / Change in cash | -1.29 Million | -746.06 Thousand | -3.85 Million | 7.17 Million | -5.43 Million | -8.6 Million |
| Free Cash Flow | -292.82 Thousand | -2.29 Million | -3.93 Million | -6.84 Million | -7.7 Million | -7.17 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -222.17 Thousand | -643.23 Thousand | -1.37 Million | -724.14 Thousand | -929.07 Thousand | -2.18 Million |
| Depreciation & Amortization | 411.13 Thousand | 389.86 Thousand | 785.96 Thousand | 389.23 Thousand | 428.34 Thousand | 921.43 Thousand |
| Deferred income taxes | - | - | -2.1 Million | - | - | -2.59 Million |
| Stock-based compensation | - | -351.42 Thousand | 342 Thousand | 83.46 Thousand | -296.14 Thousand | 249 Thousand |
| Change in working capital | -1.88 Million | 2.04 Million | -192.26 Thousand | -1.12 Million | -374.13 Thousand | -500.08 Thousand |
| Other non-cash items | 328.91 Thousand | -80.01 Thousand | 2.94 Million | 2.38 Million | 1.44 Million | 2.7 Million |
| Investing Cash Flow | -450.66 Thousand | -323.18 Thousand | -694.25 Thousand | -357.61 Thousand | -533.99 Thousand | -884.89 Thousand |
| Investments in PPE | -206.35 Thousand | -153.74 Thousand | -694.25 Thousand | -357.61 Thousand | -533.99 Thousand | -884.89 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -169.43 Thousand | -332.59 Thousand | -163.78 Thousand | -301.1 Thousand | -579.88 Thousand |
| Financing Cash Flow | 870.5 Thousand | -564 Thousand | -760.22 Thousand | -219.75 Thousand | 799.41 Thousand | 1.1 Million |
| Debt repayment | -3.35 Million | -139.66 Thousand | -191.46 Thousand | -50.27 Thousand | -944.55 Thousand | -1.38 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 82.22 Thousand | 59.05 Thousand | 59.53 Thousand | - | 720.98 | 7306.50 |
| Other Financing Activities | -2.56 Million | -564 Thousand | -628.29 Thousand | -523.64 Thousand | 559.2 Thousand | 2.48 Million |
| Accounts receivables | -673.63 Thousand | 1.26 Million | 863.19 Thousand | -437.89 Thousand | -660.29 Thousand | -569.9 Thousand |
| Accounts payables | 650.7 Thousand | -1.16 Million | -1.47 Million | -300.84 Thousand | 1 Million | 1.01 Million |
| Inventory | -1.86 Million | 784.43 Thousand | 421.54 Thousand | -385.99 Thousand | -722.68 Thousand | -944.16 Thousand |
| Other working capital | - | - | - | -1.00 | - | -1.00 |
| Cash at beginning of period | 3.64 Million | 3.2 Million | 4.94 Million | 4.94 Million | 5.08 Million | 5.69 Million |
| Cash at end of period | 2.73 Million | 3.64 Million | 3.64 Million | 3.19 Million | 4.94 Million | 4.94 Million |
| Capital Expenditure | -206.35 Thousand | -153.74 Thousand | -694.25 Thousand | -357.61 Thousand | -533.99 Thousand | -884.89 Thousand |
| Effect of forex changes on cash | - | -18.04 Thousand | 10 Thousand | 25.98 Thousand | 114.98 Thousand | -294 Thousand |
| Net cash flow / Change in cash | -909.71 Thousand | 447.51 Thousand | -1.29 Million | -1.74 Million | -136.58 Thousand | -746.06 Thousand |
| Free Cash Flow | -1.57 Million | 1.21 Million | -292.82 Thousand | -1.33 Million | -1.19 Million | -2.29 Million |
MAAL
037460
025750
RTSO
8079
001755